Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-01-25

Clinical Trial Update: MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Implant [Phase 2, Phase 3]

View source ↗

Summary

An update on the MIST II PFO-Migraine trial evaluating the BioSTAR bioabsorbable septal repair implant in patients with migraine (with aura) and patent foramen …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BioSTAR Bioabsorbable Septal Repair Implant

Snippet

Sponsor: NMT Medical | Conditions: Migraine, Aura | Phase 2, Phase 3 | Status: UNKNOWN